| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 02/09/2011 | EP1379508B9 N-(aryl)-2-arylethenesulfonamides and therapeutic uses thereof |
| 02/09/2011 | EP1370276B1 Intercellular communication facilitating compounds and their medical use |
| 02/09/2011 | EP1280898B1 Modified es cells and es cell-specific gene |
| 02/09/2011 | EP1011686B9 Modulation of human mast cell activation |
| 02/09/2011 | EP0771324B2 Concentrate of fibrinogene obtained from blood plasma, process and plant for its preparation |
| 02/09/2011 | CN1799631B Animal model for fetal alcohol syndrome and methods of treatment |
| 02/09/2011 | CN101970458A Novel gamma-secretase inhibitor |
| 02/09/2011 | CN101970442A Bicyclic pyrrole compound |
| 02/09/2011 | CN101970414A 1 ibeta-hydroxysteroid dehydrogenase inhibitors |
| 02/09/2011 | CN101970410A Pyridylaminoacetic acid compound |
| 02/09/2011 | CN101970007A Therapeutic or prophylactic agent for cerebral aneurysm |
| 02/09/2011 | CN101969963A Pharmaceutical composition and combined agent |
| 02/09/2011 | CN101969961A Cholestanol derivative for combined use |
| 02/09/2011 | CN101969953A Pterin analog for treating bh4 responsive condition |
| 02/09/2011 | CN101969932A Capsule formulation |
| 02/09/2011 | CN101967187A Protein related to cell stress, and coding gene and application thereof |
| 02/09/2011 | CN101967168A Triterpenoid saponin derivative and preparation method and application thereof |
| 02/09/2011 | CN101967146A Ep4 receptor inhibitors to treat rheumatoid arthritis |
| 02/09/2011 | CN101967138A Fatty acid schisantherin A ester compound |
| 02/09/2011 | CN101967123A 2-cyclopropyl-4-(N-methyl substituted anilino) quinoline compound as well as intermediate, preparation method and application thereof |
| 02/09/2011 | CN101455795B Traditional Chinese medicine preparation for treating spontaneous perspiration and preparation method thereof |
| 02/08/2011 | USRE42126 system for delivering oral care substance to oral cavity comprising a removable backing strip having sufficient flexibility to be conformable to oral surface and oral care composition that forms film when applied to backing strip comprising organosiloxane resin, rheology modifier, and oral care substance |
| 02/08/2011 | US7884206 Method for producing 3-amidinophenylalanine derivatives |
| 02/08/2011 | US7884204 Phenylalanine derivatives |
| 02/08/2011 | US7884179 monoclonal antibodies or antigen binding fragments that specifically to six transmembrane epithelial antigens of the prostate (STEAP-1), used for medical diagnosis, prognosis, prophylaxis and/or therapy for cancers |
| 02/08/2011 | US7883881 Unphosphorylated glycogen synthase kinase-3-g-beta (GSK) from baculovirus overexpression system; competitive binding; diabetes, Alzheimer's disease |
| 02/08/2011 | US7883880 DNA polymerase lambda and uses thereof |
| 02/08/2011 | US7883868 Nucleotide sequences coding beta -10 glycoprotein hormone use in diagnosis and prevention of thyroid gland disorders |
| 02/08/2011 | US7883714 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
| 02/08/2011 | US7883707 Induction of antigen specific immunnologic tolerance |
| 02/08/2011 | CA2622694C Substituted cycloalkene derivative |
| 02/08/2011 | CA2494300C Growth hormone releasing peptides |
| 02/08/2011 | CA2480940C Non-steroidal progesterone receptor modulators |
| 02/08/2011 | CA2479906C Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors |
| 02/08/2011 | CA2464214C Protein kinase and phosphatase inhibitors, methods for designing them, and methods of using them |
| 02/08/2011 | CA2456604C Pharmaceutical composition comprising lumiracoxib |
| 02/08/2011 | CA2446924C 2-iminopyrrolidine derivatives |
| 02/08/2011 | CA2442319C Carboxylic acid derivative and salt thereof |
| 02/08/2011 | CA2431461C 1,5 benzothiazepines and their use as antihyperlipidemics |
| 02/08/2011 | CA2295971C Pseudomonas exotoxin a-like chimeric immunogens |
| 02/08/2011 | CA2259603C Use of polymeric compositions for reducing or eliminating post-surgical adhesion formation |
| 02/08/2011 | CA2223407C Oxidant scavengers |
| 02/08/2011 | CA2210467C Osteoprotegerin |
| 02/08/2011 | CA2199940C Anti-receptor and growth blocking agents to the vitamin b12/transcobalamin ii receptor and binding sites |
| 02/03/2011 | WO2011013785A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | WO2011013752A1 Pharmaceutical composition containing fused hetero-ring derivative |
| 02/03/2011 | WO2011013729A1 Fused imidazole derivative having ttk inhibitory action |
| 02/03/2011 | WO2011013699A1 Carrier peptide fragment and use thereof |
| 02/03/2011 | WO2011013668A1 Pharmaceutical composition for treatment of ischemic events |
| 02/03/2011 | WO2011013656A1 Pyrrolo[2,3-d]pyrimidine derivative |
| 02/03/2011 | WO2011013651A1 Bicyclic compound and use thereof for medical purposes |
| 02/03/2011 | WO2011013646A1 Pharmaceutical product for prevention and treatment of amyotrophic lateral sclerosis |
| 02/03/2011 | WO2011013644A1 Substituted piperidine compound |
| 02/03/2011 | WO2011013624A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | WO2011013623A1 Indole derivative and pharmacologically acceptable salt thereof |
| 02/03/2011 | WO2011013612A1 Peptidic compound and use of same |
| 02/03/2011 | WO2011013470A1 Autoantibody production inhibitor |
| 02/03/2011 | WO2011013302A1 Agent for treatment or prevention of hepatitis |
| 02/03/2011 | WO2011012780A1 Use of rosmarinic acid and the derivatives thereof to treat ciguatera |
| 02/03/2011 | WO2010118298A3 Compositions and methods for bioactive coatings to improve allograft incorporation |
| 02/03/2011 | US20110030108 Mammalian-type glycosylation in plants |
| 02/03/2011 | US20110030075 Methods and Compositions Capable of Causing Post-Transcriptional Silencing of Gene Expression in a Synergic Manner |
| 02/03/2011 | US20110028567 Smooth muscle contraction inhibitors |
| 02/03/2011 | US20110028504 Formulation of radioprotective alpha beta unsaturated aryl sulfones |
| 02/03/2011 | US20110028491 Apoptosis inhibitor |
| 02/03/2011 | US20110028430 Injectable viscous medicinal preparation comprising ethanol and an x-ray opaque fat-soluble compound |
| 02/03/2011 | US20110028382 Treatment of oral pharyngeal dysphagia |
| 02/03/2011 | US20110027883 Rna interference mediating small rna molecules |
| 02/03/2011 | US20110027339 Porous implants and stents as controlled release drug delivery carriers |
| 02/03/2011 | US20110027338 Biologic replacement for fibrin clot |
| 02/03/2011 | US20110027335 Coated medical devices |
| 02/03/2011 | US20110027326 External Composition for Skin |
| 02/03/2011 | US20110027292 Protein Formulations with Reduced Viscosity and Uses Thereof |
| 02/03/2011 | US20110027253 Padlock probe amplification methods |
| 02/03/2011 | US20110027250 Sealants for Fetal Membrane Repair |
| 02/03/2011 | US20110027181 Device including altered microorganisms, and methods and systems of use |
| 02/03/2011 | US20110027175 Cancer imaging and treatment |
| 02/03/2011 | US20110027172 Drug delivery system for pharmaceuticals and radiation |
| 02/03/2011 | CA2768981A1 Ligands that bind tgf-beta receptor rii |
| 02/03/2011 | CA2768821A1 Pyrrolo[2,3-d]pyrimidine derivative |
| 02/03/2011 | CA2768816A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2768814A1 Indole derivative or pharmaceutically acceptable salt thereof |
| 02/03/2011 | CA2767899A1 Nitrogen-containing spiro-ring compound and medicinal use of same |
| 02/03/2011 | CA2767083A1 Bicyclic compound and use thereof for medical purposes |
| 02/02/2011 | EP2280070A1 Methods and compositions for RNAi mediated inhibition of gene expression in mammals |
| 02/02/2011 | EP2280012A2 Pyrrolo[2,1-f][1,2,4]triazine derivatives as kinase inhibitors |
| 02/02/2011 | EP2279755A2 Remodelling and glycoconjugation of Fibroblast Growth Factor (FGF) |
| 02/02/2011 | EP2279754A2 Remodelling and glycoconjugation of human growth hormone (hGH) |
| 02/02/2011 | EP2279753A2 Remodeling and glycoconjugation of peptides |
| 02/02/2011 | EP2279742A2 Combinations for the treatment of immunoinflammatory disorders |
| 02/02/2011 | EP2279739A1 Donepezil-containing patch preparation and packaging thereof |
| 02/02/2011 | EP2279737A1 Heterocyclic compounds that are active as beta lactamase inhibitors |
| 02/02/2011 | EP2279007A2 Pegylated recombinant human growth hormone compounds |
| 02/02/2011 | EP2278964A1 Use of lhrh antagonists at non-castrating doses |
| 02/02/2011 | EP1485358B1 Broadspectrum substituted benzimidazole sulfonamide hiv protease inhibitors |
| 02/02/2011 | EP1343520B1 New therapeutic uses of smr1 peptides |
| 02/02/2011 | EP1288205B1 Novel phenylalanine derivatives |
| 02/02/2011 | EP1285885B1 Method for producing high functional water containing titanium and apparatus for the same |
| 02/02/2011 | EP1039893B1 Pharmaceutical compositions containing an omega-3 fatty acid oil |
| 02/02/2011 | CN1980655B Lipase inhibitor |